Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells

Oncogene

Volumn 31, Issue 15, 2012, Pages 1963-1974

  Kurasawa, Y ^a   Kozaki, K ^a   Pimkhaokham, A ^a,b   Muramatsu, T ^a   Ono, H ^a   Ishihara, T ^a   Uzawa, N ^a   Imoto, I ^a   Amagasa, T ^a   Inazawa, J ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

DNA hypermethylation; EMT; oral squamous cell carcinoma; WNT10A; WNT7A

Indexed keywords

BETA ACTIN; MEMBRANE PROTEIN; PROTEIN ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER STAGING; DNA METHYLATION; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; WNT10A GENE; WNT7A GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHENOTYPE; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84859747203     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.373     Document Type: Article

References (30)

1. Berdasco M, Esteller M. (2010). Aberrant epigenetic landscape incancer: how cellular identity goes awry. Dev cell 19: 698-711.
2. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, ShannonMF et al. (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymaltransition. Cancer Res 68: 7846-7854.
3. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna Set al. (2008). A reciprocal repression between ZEB1 and members ofthe miR-200 family promotes EMT and invasion in cancer cells.EMBO Rep 9: 582-589. (Pubitemid 351772923)
4. Chuang JC, Jones PA. (2007). Epigenetics and microRNAs. PediatrRes 61: 24R-29R. (Pubitemid 46653064)
5. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. (2008). Sustained induction of epithelialto mesenchymal transition activates DNA methylation of genessilenced in basal-like breast cancers. Proc Natl Acad Sci USA 105:14867-14872.
6. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber Met al. (2005). DeltaEF1 is a transcriptional repressor of E-cadherinand regulates epithelial plasticity in breast cancer cells. Oncogene 24:2375-2385. (Pubitemid 40546696)
7. Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J.(2009). miR-124 and miR-203 are epigenetically silenced tumorsuppressivemicroRNAs in hepatocellular carcinoma. Carcinogenesis31: 766-776.
8. Greenlee RT, Murray T, Bolden S, Wingo PA. (2000). Cancerstatistics, 2000. CA Cancer J Clin 50: 7-33.
9. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid Get al. (2008). The miR-200 family and miR-205 regulate epithelial tomesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol10: 593-601. (Pubitemid 351627379)
10. Ha PK, Califano JA. (2006). Promoter methylation and inactivation oftumour-suppressor genes in oral squamous-cell carcinoma. LancetOncol 7: 77-82. (Pubitemid 43025396)
11. Herman JG, Baylin SB. (2003). Gene silencing in cancer in associationwith promoter hypermethylation. N Engl J Med 349: 2042-2054. (Pubitemid 37448928)
12. Kalluri R, Weinberg RA. (2009). The basics of epithelial- mesenchymaltransition. J Clin Invest 119: 1420-1428.
13. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. (2008). Explorationof tumor-suppressive microRNAs silenced by DNA hypermethylationin oral cancer. Cancer Res 68: 2094-2105. (Pubitemid 351521781)
14. Nomura K, Sobue T, Nakatani H, Maehara M, Kiryu Y, Tsukuma H, et al., The Editorial Board of Cancer Statistics in Japan. (2005).Number of deaths and proportional mortality rates from malignantneoplasms by site in Japan. Cancer Statistics in Japan 2003 (http://ganjoho.jp/public/statistics/backnumber/2010- en.html), pp 36-39.
15. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M et al.(2010). Pancreatic cancers epigenetically silence SIP1 and hypomethylateand overexpress miR-200a/200b in association withelevated circulating miR-200a and miR-200b levels. Cancer Res70: 5226-5237.
16. McNeill H, Woodgett JR. (2010). When pathways collide: collaborationand connivance among signalling proteins in development.Nature 11: 404-413.
17. Moustakas A, Heldin CH. (2007). Signaling networks guidingepithelial- mesenchymal transitions during embryogenesis andcancer progression. Cancer Sci 98: 1512-1520. (Pubitemid 47308444)
18. Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla Eet al. (2003). WNT7a induces E-cadherin in lung cancer cells. ProcNatl Acad Sci USA 100: 10429-10434. (Pubitemid 37071895)
19. Ordway JM, Bedell JA, Citek RW, Nunberg A, Garrido A, Kendall Ret al. (2006). Comprehensive DNA methylation profiling in a humancancer genome identifies novel epigenetic targets. Carcinogenesis 27:2409-2423. (Pubitemid 44884098)
20. Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U et al.(2010). Smad signaling is required to maintain epigenetic silencingduring breast cancer progression. Cancer Res 70: 968-978.
21. Park SM, Gaur AB, Lengyel E, Peter ME. (2008). The miR-200 familydetermines the epithelial phenotype of cancer cells by targeting theE-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. (Pubitemid 351482843)
22. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics,2002. CA Cancer J Clin 55: 74-108.
23. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, CameronJL et al. (2003). Discovery of novel targets for aberrant methylationin pancreatic carcinoma using high-throughput microarrays. CancerRes 63: 3735-3742. (Pubitemid 36793060)
24. Scully C, Field JK, Tanzawa H. (2000). Genetic aberrations in oral orhead and neck squamous cell carcinoma (SCCHN): 1. Carcinogenmetabolism, DNA repair and cell cycle control. Oral Oncol 36:256-263. (Pubitemid 30227706)
25. Song Y, Washington MK, Crawford HC. (2010). Loss of FOXA1/2 isessential for the epithelial-to-mesenchymal transition in pancreaticcancer. Cancer Res 70: 2115-2125.
26. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, KozakiK et al. (2007). PRTFDC1, a possible tumor-suppressor gene, isfrequently silenced in oral squamous-cell carcinomas by aberrantpromoter hypermethylation. Oncogene 26: 7921-7932. (Pubitemid 350261784)
27. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M. (2003). Down-regulation of Wnt-4 and up-regulationof Wnt-5a expression by epithelial-mesenchymal transition inhuman squamous carcinoma cells. Cancer Sci 94: 593-597. (Pubitemid 36975013)
28. Thiery JP, Acloque H, Huang RY, Nieto MA. (2009). Epithelialmesenchymaltransitions in development and disease. Cell 139:871-890.
29. Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, HammondM et al. (2005). Restoration of Wnt-7a expression reverses nonsmallcell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.J Biol Chem 280: 19625-19634. (Pubitemid 41379485)
30. Yang J, Weinberg RA. (2008). Epithelial-mesenchymal transition:at the crossroads of development and tumor metastasis. Dev Cell 14:818-829. (Pubitemid 351757205)